Study Guide: Pharmacology | 3S | Before Class

Before You Begin

NurseAdemy | Pharmacology III • Medication Safety & Clinical Judgment

Pre-Class Preparation

This guide introduces the pharmacology concepts needed for the workbook without revealing the correct selections, completing the clinical scenarios, or identifying the exact answer for any case.

Use it to review medication families, laboratory interpretation, toxicity patterns, interactions, and prioritization principles. During class, you will apply these concepts to determine the most appropriate nursing response.

NurseAdemy Key Point:
Do not search for a single memorized keyword. Analyze the full pattern: medication history, symptom onset, vital signs, laboratory trends, organ function, and the risk created by delaying care.

1. Severe Reactions to Neurologic and Psychiatric Medications

Some neurologic and psychiatric medications can produce severe reactions involving temperature, muscle tone, mental status, and autonomic function. Review how to distinguish a life-threatening systemic reaction from a localized movement disorder.

Temperature Determine whether the client has mild fever or extreme hyperthermia.

Muscle Findings Compare generalized rigidity with clonus, hyperreflexia, tremor, or focal spasms.

Mental Status Note confusion, agitation, mutism, decreased responsiveness, or rapid changes.

Laboratory Clues Review creatine kinase, white blood cell count, renal function, and electrolytes.

Clinical Thinking: A severe medication reaction is identified by the combination of findings—not by one symptom alone.

2. Parkinson Medications and Abnormal Movements

Medications used for Parkinson disease may improve tremor and mobility while also producing new movement-related adverse effects. Pay close attention to the timing of symptoms in relation to the dose.

Therapeutic Response Identify which original Parkinson symptoms have improved.

New Movement Pattern Describe twisting, repetitive facial movements, lip movements, or involuntary extremity activity.

Timing Determine whether symptoms appear before a dose, after a dose, or near peak effect.

Functional Impact Assess safety, mobility, nutrition, communication, and fall risk.

3. Anticoagulants, Laboratory Trends, and Bleeding

Anticoagulant questions require more than recognizing an abnormal laboratory value. Determine whether the client has evidence of active bleeding, reduced perfusion, or another complication.

Assessment Area	What to Review
Visible or Occult Bleeding	Skin, gums, urine, stool, emesis, IV sites, and neurologic changes
Laboratory Trends	Coagulation values, hemoglobin, hematocrit, and platelets
Hemodynamic Stability	Blood pressure, heart rate, dizziness, pallor, and orthostatic symptoms
Medication Review	Prescription drugs, OTC medications, supplements, and recent dose changes

Do not assume that every abnormal anticoagulation value requires the same intervention. The client’s symptoms and stability determine urgency.

4. Endocrine Medications and Priority Classification

For endocrine medications, classify each finding as a therapeutic response, an expected adverse effect, a finding that may require holding a dose, or a complication requiring urgent provider notification.

Medication Group	Review Before Class
Rapid-Acting Insulin	Meal timing, glucose level, symptoms of hypoglycemia, and access to food
Long-Acting Insulin	Basal coverage, fasting trends, and ongoing hypoglycemia risk
Antithyroid Medication	Fever, sore throat, mouth changes, and white blood cell abnormalities
Thyroid Replacement	Heart rate, temperature tolerance, dose adherence, and symptoms of excessive replacement
Corticosteroid	Glucose, appetite, weight, fluid retention, infection risk, and long-term effects

NCLEX Rule: “Expected” does not mean “ignore.” Some expected adverse effects still require monitoring and follow-up.

5. Medication Reconciliation and Formulation Safety

Medication safety questions may involve a mismatch between the MAR, the provider order, and the pharmacy label. Similar names or the same generic ingredient do not automatically mean that two products are interchangeable.

Compare Review the MAR, original order, label, dose, route, formulation, and frequency.

Clarify Identify who should be contacted when information does not match.

Protect the Client Avoid administering a medication while a meaningful discrepancy remains unresolved.

Document Follow the organization’s medication safety policy.

6. Supplements and Prescription Medication Interactions

Vitamins and herbal products can alter bleeding risk, medication absorption, electrolyte levels, and therapeutic effectiveness. Include all nonprescription products in medication reconciliation.

Interaction Category	What to Consider
Bleeding Risk	Supplements used with anticoagulants or antiplatelet medications
Absorption	Minerals taken close to medications that require consistent absorption
Potassium Changes	Supplements combined with medications that raise or lower potassium
Reduced Medication Effect	Herbal products that increase metabolism of prescription medications

“Natural” does not mean free of adverse effects or medication interactions.

7. Magnesium Therapy and Toxicity Monitoring

When magnesium is administered intravenously, the nurse should monitor the systems most affected by rising magnesium levels and consider how renal function influences elimination.

Respiratory Status Monitor rate, depth, oxygenation, and signs of respiratory depression.

Neurologic Status Assess level of consciousness and deep tendon reflexes.

Renal Function Review urine output and creatinine because impaired clearance increases toxicity risk.

Emergency Preparation Know the facility protocol and reversal medication used for severe toxicity.

Clinical Thinking: A rising serum level is important, but bedside findings often reveal deterioration first.

8. Bronchodilators, Therapeutic Response, and Adverse Effects

Bronchodilators may improve airflow while producing systemic effects. Compare respiratory improvement with heart rate, tremor, restlessness, glucose, and potassium.

Respiratory Response Review wheezing, retractions, oxygenation, respiratory rate, and breath sounds.

Cardiovascular Effects Monitor tachycardia, palpitations, and rhythm changes.

Neuromuscular Effects Assess tremor, restlessness, and subjective reports of a racing heart.

Electrolyte Effect Consider whether therapy can shift potassium between the blood and the cells.

9. Polypharmacy, Heart Failure, and Kidney Disease

In clients with heart failure and chronic kidney disease, several medications may create additive risks. Evaluate the entire medication profile together with potassium, creatinine, drug levels, and bleeding risk.

Risk Area	Medication Review Questions
Duplicate Therapy	Are two medications affecting the same pathway without a clear reason?
Hyperkalemia	Which medications or supplements may raise potassium together?
Renal Safety	Could the medication accumulate or worsen kidney function?
Drug Toxicity	Is a serum medication level above the expected range?
Bleeding	Are prescribed anticoagulants combined with products that increase bleeding?

10. Bisphosphonates and Safe Administration

Oral bisphosphonates can irritate the esophagus. Review the required administration technique and recognize symptoms that may indicate esophageal injury.

Fluid Identify the recommended beverage and adequate volume.

Position Review how long the client should remain upright.

Timing Consider the relationship to food and other medications.

Warning Symptoms Dysphagia, painful swallowing, or new chest discomfort require evaluation.

11. Potassium Abnormalities and ECG Recognition

Potassium abnormalities may result from medications, supplements, renal impairment, gastrointestinal losses, or therapies that shift potassium between compartments.

Review Area	Questions to Ask
Medication Cause	Which medications raise potassium, lower potassium, or shift it into cells?
Renal Contribution	Can the client excrete potassium effectively?
ECG Pattern	Does the rhythm suggest altered repolarization or conduction?
Treatment Goal	Does the therapy stabilize the heart, shift potassium, or remove potassium?

Clinical Thinking: Do not confuse cardiac stabilization with actual removal of potassium from the body.

12. Priority Nursing Actions

In SATA, matrix, and Bow Tie questions, several actions may sound reasonable. Select the responses that address immediate safety and the suspected medication-related threat.

Assess Stability Airway, breathing, circulation, mental status, rhythm, perfusion, and active bleeding.

Prevent Further Harm Determine whether continued medication administration could worsen the condition.

Escalate Appropriately Notify the appropriate clinician when findings indicate toxicity or instability.

Monitor the Threatened System Choose parameters that directly show deterioration or improvement.

Teaching and long-term management are important, but they do not replace immediate stabilization.

Before Completing Each Case

Identify the purpose and medication class of each drug.
Review when the medication was administered and what changed afterward.
Compare current findings with baseline and normal ranges.
Look for duplicate therapies, drug-supplement interactions, and organ dysfunction.
Classify findings as therapeutic, expected adverse, unexpected, or toxic.
Determine which body system is at greatest immediate risk.
Choose the assessment or intervention that most directly protects the client.

Final Question:
What pattern is present, what additional information confirms it, and which action prevents the greatest immediate harm—without jumping directly to a memorized answer?